Ownership

Christopher Yea - CHIEF DEVELOPMENT OFFICER at KalVista Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type: Individual
Role: Chief Development Officer
Stock Symbol: KALV on Nasdaq
Industry: Pharmaceutical Preparations
All Insider Reports: All Insider Reports

Christopher Yea - trading volume in the past year for KalVista Pharmaceuticals, Inc.

	Shares	%	Avg Price	Total $
Buys
Sells	-81.7K	100%	$13.47	-$1.1M
Net	-81.7K	-100%		-$1.1M

Holdings reported by Christopher Yea for KalVista Pharmaceuticals, Inc.

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	91.1K	$900K	$9.87	Nov 26, 2024	Direct
Restricted Stock Units	50K	$588K	$11.76	May 22, 2024	Direct	Common Stock
Restricted Stock Unit	43.8K	$405K	$9.26	Nov 22, 2024	Direct	Common Stock
Performance Stock Units	0	$0	$9.26	Nov 17, 2024	Direct	Common Stock

Transactions reported by Christopher Yea for KalVista Pharmaceuticals, Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.